MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20186/30/20176/30/20166/30/2015
Total Revenue772,600769,900740,500723,100
Cost of Revenue177,200171,200157,300147,400
Gross Profit595,400598,700583,200575,700
Operating Expenses
Research Development70,80074,40070,60075,500
Selling General and Administrative467,100476,400359,200366,000
Non Recurring----
Others----
Total Operating Expenses715,100722,000587,100588,900
Operating Income or Loss57,50047,900153,400134,200
Income from Continuing Operations
Total Other Income/Expenses Net59,400-7,0002,600700
Earnings Before Interest and Taxes57,50047,900153,400134,200
Interest Expense-3,200-6,000-300-200
Income Before Tax116,90040,900156,000134,900
Income Tax Expense-14,00020,60038,80054,700
Minority Interest--400-400-400
Net Income From Continuing Ops130,90020,300117,20080,200
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income131,10020,500117,20080,200
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares131,10020,500117,20080,200